209 related articles for article (PubMed ID: 12932592)
1. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).
Carlson MD; Ip J; Messenger J; Beau S; Kalbfleisch S; Gervais P; Cameron DA; Duran A; Val-Mejias J; Mackall J; Gold M;
J Am Coll Cardiol; 2003 Aug; 42(4):627-33. PubMed ID: 12932592
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
[TBL] [Abstract][Full Text] [Related]
4. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia.
Lau CP; Tse HF; Yu CM; Teo WS; Kam R; Ng KS; Huang SS; Lin JL; Fitts SM; Hettrick DA; Hill MR;
Am J Cardiol; 2001 Aug; 88(4):371-5. PubMed ID: 11545756
[TBL] [Abstract][Full Text] [Related]
5. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
[TBL] [Abstract][Full Text] [Related]
6. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
[TBL] [Abstract][Full Text] [Related]
7. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
9. Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation.
Menezes Ada S; Martinelli Filho M; Menezes CC; Costa R; Ramires JA
Arq Bras Cardiol; 2007 Jan; 88(1):1-7. PubMed ID: 17364111
[TBL] [Abstract][Full Text] [Related]
10. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
[TBL] [Abstract][Full Text] [Related]
11. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
[TBL] [Abstract][Full Text] [Related]
12. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
Filipecki A; Saksena S; Lin WH
Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
[TBL] [Abstract][Full Text] [Related]
14. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up.
Russo V; Nigro G; Rago A; Antonio Papa A; Proietti R; Della Cioppa N; Cristiano A; Palladino A; Calabrò R; Politano L
Acta Myol; 2013 Dec; 32(3):142-7. PubMed ID: 24803841
[TBL] [Abstract][Full Text] [Related]
17. Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study.
Russo V; Papa AA; Rago A; Ciardiello C; Nigro G
Heart Rhythm; 2018 Jul; 15(7):962-968. PubMed ID: 29524476
[TBL] [Abstract][Full Text] [Related]
18. Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation.
Pürerfellner H; Urban L; de Weerd G; Ruiter J; Brandt J; Havlicek A; Hügl B; Widdershoven J; Kornet L; Kessels R
Europace; 2009 Jan; 11(1):62-9. PubMed ID: 19008238
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360
[TBL] [Abstract][Full Text] [Related]
20. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
